We previously demonstrated that Axl is a relevant therapeutic target for mCRPCa; Axl blockage inhibits the proliferation and migration of PCa cells as well as tumor formation in vivo5, we tested the hypothesis that DHA inhibits proliferation of mCRPCa cells via Axl modulation. The gene discussed is AXL; the disease is posterior cortical atrophy.